Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Anthocyanins are naturally occurring flavonoids found in deeply colored fruits and vegetables such as berries, red cabbage, and purple sweet potatoes. The use of anthocyanins to support or treat Chronic Obstructive Pulmonary Disease (COPD) is based on their potent antioxidant and anti-inflammatory properties, which have been explored in several preclinical and epidemiological studies. Oxidative stress and chronic inflammation are central mechanisms in the pathogenesis of COPD, leading to progressive lung damage and decline in respiratory function.

Scientific evidence suggests that anthocyanins can reduce oxidative stress by scavenging free radicals and by modulating inflammatory pathways, such as NF-κB and MAPK. Some observational studies have found that higher intake of anthocyanin-rich foods is associated with improved lung function and reduced risk of COPD or its exacerbations. In vitro and animal studies have demonstrated that anthocyanins may protect lung tissue from cigarette smoke-induced damage and decrease inflammatory cytokine production.

However, the direct clinical evidence in humans with COPD is limited, with a lack of large randomized controlled trials specifically targeting anthocyanin supplementation in this population. Most human studies are observational and cannot establish causality. Thus, while there is a plausible scientific rationale and preliminary supportive data, the overall level of evidence remains low to moderate. More rigorous clinical trials are needed to confirm potential benefits and to determine effective dosing in COPD management.

More about anthocyanins
More about Chronic Obstructive Pulmonary Disorder

Other ingredients used for Chronic Obstructive Pulmonary Disorder

Other health conditions supported by anthocyanins

Products containing anthocyanins